首页 > 资讯 > Welldoc提供的数据显示，使用数字健康工具和人工智能指导可以减肥和改善健康措施，迄今已增加了75多篇出版物

Welldoc提供的数据显示，使用数字健康工具和人工智能指导可以减肥和改善健康措施，迄今已增加了75多篇出版物

泰然健康网
2025-07-20 09:04

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a digital health leader revolutionizing chronic care, today announced data demonstrating that the use of a digital health application in a virtual program for individuals with type 2 diabetes was associated with significant improvements in weight loss, as well as favorable trends in post-meal blood glucose and systolic blood pressure.

哥伦比亚医学博士-（商业线）-Welldoc®，一位彻底改变慢性病护理的数字健康领导者，今天宣布数据证明，在虚拟程序中为2型糖尿病患者使用数字健康应用程序与显着相关体重减轻的改善，以及餐后血糖和收缩压的有利趋势。

The data, which were presented as a clinical research poster at the 18th Annual Cardiometabolic Health Congress in Boston, capture the results of a real-world study in which individuals were given access to the Welldoc App, which provides continuous AI-driven digital coaching designed to support self-management behaviors..

这些数据在波士顿第18届年度心脏代谢健康大会上作为临床研究海报展示，捕捉了一项真实世界研究的结果，在这项研究中，个人可以访问Welldoc应用程序，该应用程序提供持续的AI驱动的数字辅导旨在支持自我管理行为。。

Data show that the average weight at the endpoint was significantly lower than the baseline (227.8 to 211.8 pounds, p=0.007), with over 77% of participants losing an average of 4.8% of their baseline body weight. There were also statistically significant improvements in systolic blood pressure and favorable post-meal blood glucose trends.

数据显示，终点的平均体重显着低于基线（227.8至211.8磅，p=0.007），超过77%的参与者平均失去基线体重的4.8%。收缩压和有利的餐后血糖趋势也有统计学显着改善。

These data demonstrate how overall cardiovascular risk can be reduced in a high-risk population at scale, validating Welldoc’s approach to developing next-generation digital health solutions..

这些数据展示了如何在高风险人群中大规模降低总体心血管风险，验证了Welldoc开发下一代数字健康解决方案的方法。。

“With half of the rapidly expanding type 2 diabetes population having or being at-risk for cardiovascular disease,1 as well as a worsening global shortage of healthcare professionals,2 it’s critical to offer a holistic solution which guides individuals through all aspects of their chronic conditions and comorbidities.

“随着快速增长的2型糖尿病人群中有一半患有心血管疾病或处于心血管疾病风险之中，1以及全球医疗保健专业人员短缺加剧，2提供全面的解决方案至关重要，该解决方案可指导个人完成其各方面的工作。慢性病和合并症。

Digital health offers the opportunity to scale care, lessen the burden on individuals living with these conditions, improve efficiencies for clinicians, and reduce unsustainable medical costs,” said Dr. Mansur Shomali, Chief Medical Officer of Welldoc. “With this research we can clearly see the value of digital health tools which incorporate personalized AI-driven coaching.

Welldoc首席医疗官Mansur Shomali博士说，数字健康提供了扩大护理规模，减轻患有这些疾病的个人负担，提高临床医生效率和降低不可持续医疗成本的机会。“通过这项研究，我们可以清楚地看到数字健康工具的价值，其中包含个性化AI驱动的辅导。

The ability to improve multiple cardiometabolic outcomes in a high-risk population demonstrates the potential of our solution to amplify the benefits of provider visits for individuals with multiple conditions.”.

在高风险人群中改善多种心脏代谢结果的能力表明，我们的解决方案有可能扩大提供者访问对多种疾病患者的益处“。

Welldoc’s comprehensive platform provides digital coaching across multiple chronic conditions and comorbidities, including type 1 and type 2 diabetes, heart failure, prediabetes, hypertension, and weight management, with integrated mental well-being tools.

Welldoc的综合平台提供多种慢性病和合并症的数字辅导，包括1型和2型糖尿病，心力衰竭，前驱糖尿病，高血压和体重管理，以及综合心理健康工具。

The company’s AI-driven, total health approach to chronic care continues to lead the industry, as demonstrated by Welldoc’s 78 clinical publications, 42 patents, 11 FDA 510(k) Clearances for type 1 and type 2 diabetes and several awards to date for innovation, AI, and integration into real-world healthcare models..

正如Welldoc的78份临床出版物，42项专利，11项FDA 510（k）对1型和2型糖尿病的批准以及迄今为止的多项创新奖所证明的那样，该公司的人工智能驱动的全面健康方法继续引领该行业。，人工智能，并融入现实世界的医疗保健模式。。

For more information on Welldoc’s clinical research, visit: https://www.welldoc.com/clinical-research/

有关Welldoc临床研究的更多信息，请访问：https://www.welldoc.com/clinical-research/

1National Diabetes Statistics Report website. https://www.cdc.gov/diabetes/data/statistics-report/index.html. Accessed October 11, 2023.

1国家糖尿病统计报告网站。https://www.cdc.gov/diabetes/data/statistics-report/index.html.访问时间：2023年10月11日。

2Dall T, West T, Chakrabarti R, et al: The Complexities of Physician Supply and Demand: Projections from 2016 to 2030, American Association of Medical Colleges, Washington DC, 2018.

2Dall T，West T，Chakrabarti R等人：医生供需的复杂性：2016年至2030年的预测，美国医学院协会，华盛顿特区，2018年。

Welldoc®, a digital health leader revolutionizing chronic care, is integrating personalized, real-time and actionable insights into the daily lives of individuals living with chronic conditions, enabling improved health and outcomes. Welldoc’s comprehensive chronic care platform provides multi-condition support across pre-diabetes, diabetes, hypertension, heart failure, weight and obesity management, and mental wellbeing.

Welldoc®是彻底改变慢性病护理的数字健康领导者，它将个性化，实时和可行的见解融入慢性病患者的日常生活中，从而改善健康和结果。Welldoc的综合慢性护理平台为糖尿病前期，糖尿病，高血压，心力衰竭，体重和肥胖管理以及心理健康提供多种条件支持。

Welldoc’s flagship product, BlueStar®, an FDA-cleared digital health solution, guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. Welldoc partners with health plans, health systems and employers with the goal of extending care, improving health and reducing costs.

Welldoc的旗舰产品BlueStar®是FDA批准的数字健康解决方案，通过使他们能够自我管理护理，同时加强与医疗团队的联系，指导个人完成复杂的糖尿病生活历程。Welldoc与健康计划，卫生系统和雇主合作，旨在扩大护理范围，改善健康状况并降低成本。

Welldoc continues to be recognized for our leadership, innovation and partnership across the healthcare industry. This year, Welldoc was named the “Best Overall Digital Health Company” by MedTech Breakthrough and received the Innovation and AI Excellence Awards from Business Intelligence Group. In addition to achieving 11 510(k) clearances for its digital health platform designed to support diabetes health, Welldoc has also built an IP portfolio of 42 patents for its advanced AI and first-in-class tech and currently has more than 75 clinical publications.

Welldoc继续得到我们在整个医疗行业的领导，创新和伙伴关系的认可。今年，Welldoc被MedTech突破评为“最佳整体数字健康公司”，并获得了商业智能集团的创新和AI卓越奖。除了为其旨在支持糖尿病健康的数字健康平台实现11 510（k）许可之外，Welldoc还为其先进的AI和一流技术建立了42项专利的IP组合，目前拥有超过75项临床出版物。

Among Welldoc’s extensive library of clinical research, Welldoc has 17 publications focused on understanding the value of combining CGM with AI-powered digital health solutions. For more information, visit www.welldoc.com. Follow us on LinkedIn and Twitter..

在Welldoc广泛的临床研究图书馆中，Welldoc有17篇出版物专注于理解将CGM与AI驱动的数字健康解决方案相结合的价值。欲了解更多信息，请访问www.welldoc.com。在LinkedIn和Twitter上关注我们。。